EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bacteriophages: A Challenge for Antimicrobial Therapy

Nallelyt Segundo-Arizmendi iD, Dafne Arellano-Maciel, Abraham Rivera-Ramírez iD, Adán Manuel Piña-González, Gamaliel López-Leal iD, Efren Hernández-Baltazar iD

Microorganisms · 07.01.2025 · 13 (1) · 100

DOI: 10.3390/microorganisms13010100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 07.01.2025. Verfasst von Nallelyt Segundo-Arizmendi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Microbiología y Parasitología, Facultad de Farmacia de la, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phage therapy, which involves the use of bacteriophages (phages) to combat bacterial infections, is emerging as a promising approach to address the escalating threat posed by multidrug-resistant (MDR) bacteria. This brief review examines the historical background and recent advancements in phage research, focusing on their genomics, interactions with host bacteria, and progress in medical and biotechnological applications. Additionally, we expose key aspects of the mechanisms of action, and therapeutic uses of phage considerations in treating MDR bacterial infections are discussed, particularly in the context of infections related to virus–bacteria interactions.

Schlagwörter

Stichwörter der Autor:innen

CRISPRantimicrobial resistancebiofilm inhibitionmultidrug-resistant bacteria (MDR)phage stabilityphage therapyphage-based therapeuticssynthetic biology

Autor:innen und Institutionen

  • Laboratorio de Microbiología y Parasitología, Facultad de Farmacia de la, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
  • Laboratorio de Biología Computacional y Virómica Integrativa, Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
  • Laboratorio de Estudios Ecogenómicos, Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
  • Laboratorio 1 de Tecnología Farmacéutica, Facultad de Farmacia de la, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.

ORCID-Profile: Nallelyt Segundo-Arizmendi, Abraham Rivera-Ramírez, Gamaliel López-Leal, Efren Hernández-Baltazar

Zitieren

APA

Segundo-Arizmendi, N., Arellano-Maciel, D., Rivera-Ramírez, A., Piña-González, A. M., López-Leal, G., & Hernández-Baltazar, E. (2025). Bacteriophages: A Challenge for Antimicrobial Therapy. Microorganisms, 13(1), 100. https://doi.org/10.3390/microorganisms13010100

Vancouver

Segundo-Arizmendi N, Arellano-Maciel D, Rivera-Ramírez A, Piña-González AM, López-Leal G, Hernández-Baltazar E. Bacteriophages: A Challenge for Antimicrobial Therapy. Microorganisms. 2025;13(1):100. doi:10.3390/microorganisms13010100

BibTeX
@article{SegundoArizmendi2025,
  author = {Segundo-Arizmendi, Nallelyt and Arellano-Maciel, Dafne and Rivera-Ramírez, Abraham and Piña-González, Adán Manuel and López-Leal, Gamaliel and Hernández-Baltazar, Efren},
  title = {Bacteriophages: A Challenge for Antimicrobial Therapy},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {100},
  doi = {10.3390/microorganisms13010100}
}
Kostenlos starten →